228 related articles for article (PubMed ID: 18813847)
1. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.
Yfanti C; Mengele K; Gkazepis A; Weirich G; Giersig C; Kuo WL; Tang WJ; Rosner M; Schmitt M
Int J Mol Med; 2008 Oct; 22(4):421-31. PubMed ID: 18813847
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels.
Radulescu RT; Hufnagel C; Luppa P; Hellebrand H; Kuo WL; Rosner MR; Harbeck N; Giersig C; Meindl A; Schmitt M; Weirich G
Int J Oncol; 2007 Jan; 30(1):73-80. PubMed ID: 17143514
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.
Weirich G; Mengele K; Yfanti C; Gkazepis A; Hellmann D; Welk A; Giersig C; Kuo WL; Rosner MR; Tang WJ; Schmitt M
Biol Chem; 2008 Nov; 389(11):1441-5. PubMed ID: 18783335
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
Kuo WL; Montag AG; Rosner MR
Endocrinology; 1993 Feb; 132(2):604-11. PubMed ID: 7678795
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
6. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
Authier F; Rachubinski RA; Posner BI; Bergeron JJ
J Biol Chem; 1994 Jan; 269(4):3010-6. PubMed ID: 8300632
[TBL] [Abstract][Full Text] [Related]
7. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
[TBL] [Abstract][Full Text] [Related]
8. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
Fawcett J; Permana PA; Levy JL; Duckworth WC
Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
[TBL] [Abstract][Full Text] [Related]
9. Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).
Bai JP; Hsu MJ; Shier WT
Pharm Res; 1995 Apr; 12(4):513-7. PubMed ID: 7596985
[TBL] [Abstract][Full Text] [Related]
10. Functional human insulin-degrading enzyme can be expressed in bacteria.
Chesneau V; Rosner MR
Protein Expr Purif; 2000 Jun; 19(1):91-8. PubMed ID: 10833395
[TBL] [Abstract][Full Text] [Related]
11. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
12. Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme.
Akiyama H; Yokono K; Shii K; Ogawa W; Taniguchi H; Baba S; Kasuga M
Biochem Biophys Res Commun; 1990 Aug; 170(3):1325-30. PubMed ID: 2202301
[TBL] [Abstract][Full Text] [Related]
13. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
15. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
Kuo WL; Gehm BD; Rosner MR
Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
[TBL] [Abstract][Full Text] [Related]
17. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
Affholter JA; Hsieh CL; Francke U; Roth RA
Mol Endocrinol; 1990 Aug; 4(8):1125-35. PubMed ID: 2293021
[TBL] [Abstract][Full Text] [Related]
18. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.
Bai JP; Chang LL
Pharm Res; 1995 Aug; 12(8):1171-5. PubMed ID: 7494830
[TBL] [Abstract][Full Text] [Related]
19. Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.
Pivovarova O; Gögebakan O; Pfeiffer AF; Rudovich N
Diabetologia; 2009 Aug; 52(8):1656-64. PubMed ID: 19396426
[TBL] [Abstract][Full Text] [Related]
20. In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.
Zhang WJ; Luo X; Guo ZY
Protein J; 2010 Feb; 29(2):93-8. PubMed ID: 20082125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
